Endurance Longevity Signed Exclusive Licence Agreement to Commercialise Fortacin™ in the Israeli and Balkan regions
HONG KONG, Dec. 15, 2021 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) announced that Plethora Solutions Limited (Solutions), a wholly owned subsidiary of the Company has entered into an exclusive Licence Agreement with K.S. KIM International (SK-Pharma) Ltd. on 14 December 2021 in respect of the rights to...
Fullife Healthcare receives funding from Morgan Stanley Private Equity Asia
~ The investment will be instrumental in accelerating the growth of flagship brands Fast&Up and Chicnutrix ~ MUMBAI, India, Dec. 15, 2021 /PRNewswire/ -- Fullife Healthcare raised its Series C funding of over US$22 million by Morgan Stanley Private Equity Asia (MSPEA). Fullife Healthcare is the pioneer manufacturer in effervescent technology for healthcare and nutraceutical products. The company owns flagship...
Red Seal brings New Zealand’s #1 best-selling herbal and mineral toothpaste to Pharmaca Integrative Pharmacies, USA
AUCKLAND, New Zealand, Dec. 15, 2021 /PRNewswire/ -- Wednesday 14 December, 2021, Red Seal is proud to announce their herbal and mineral toothpastes are now conveniently available at all 28 distinguished Pharmaca stores nationwide. www.redseal.global/usa Pharmaca, recently named to Newsweek's list of America's Best Trending Online Shops is the nation's first integrative...
JW Therapeutics Presents Primary Clinical Response on Carteyva(R) (relmacabtagene autoleucel injection) in Adults with Relapsed/Refractory Follicular Lymphoma in China at the 63rd ASH Annual Meeting
SHANGHAI, Dec. 15, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, presented the primary clinical response on Carteyva® (relmacabtagene autoleucel injection) in adults with relapsed/refractory follicular lymphoma (r/r FL) in China at the 63rd American Society of Hematology (ASH) Annual Meeting. As of the data cut-off of...
RemeGen Reiterates Commitment to Its Battle Against Autoimmune Disease on World Strengthened Immunity Day 2021
YANTAI, China, Dec. 15, 2021 /PRNewswire/ -- To celebrate World Strengthened Immunity Day, RemeGen Co., Ltd. (9995.HK), a commercial-ready biotechnology company, reiterated its commitment to discovering, developing, and producing best-in-class biological drugs for autoimmune diseases, to create clinical value, and meet the major unmet clinical needs of the world. Since 1988, December 15 has been marked as World...
GenScript Receives “COVID Management Initiative of the Year” in Singapore Business Review Management Excellence Award 2021
SINGAPORE, Dec. 15, 2021 /PRNewswire/ -- GenScript receives the award on COVID Management Initiative of the Year, Biotechnology industry in the Singapore Business Review (SBR) Management Excellence Award 2021. GenScript showed strong commitment and support to global COVID-19 management including production of genes, proteins and peptides for SARS-CoV-2 vaccine development around the world and launched first FDA EUA (Emergency...
Everest Medicines Announces the Acceptance of a New Drug Application for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer in South Korea
SHANGHAI, Dec. 15, 2021 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, announced today that the Ministry of Food and Drug Safety (MFDS) of South Korea accepted its New Drug Application (NDA) for Sacituzumab Govitecan ("SG")...
International Volunteer Day: Infinitus volunteers provide 101,000 hours of volunteer services over five-year period
GUANGZHOU, China, Dec. 15, 2021 /PRNewswire/ -- December 5, 2021 marked the 36th anniversary of International Volunteer Day. With China embarking on its next phase of growth, the country has brought its social welfare services to a new level by improving people's livelihoods and well-being while building up a social governance model based on collaboration, participation and common...
Limbach Group adopts QuantaMatrix dRAST™ in routine clinical use
QuantaMatrix's direct Rapid Antimicrobial Susceptibility Testing system (dRAST) improves optimal prescription of antibiotics by two days compared to conventional methods Following successful validation of dRAST platform in Europe at key reference laboratories, system now adopted for clinical use PARIS and SEOUL, South Korea, Dec. 15, 2021 /PRNewswire/ -- QuantaMatrix, an in vitro diagnostics company specializing in...
Argon Medical Devices, Inc. Acquires Matrex Mold and Tool, Inc.
FRISCO, Texas, Dec. 15, 2021 /PRNewswire/ -- Argon Medical Devices, Inc., a leading manufacturer of medical devices for interventional procedures, announced the acquisition of Wisconsin-based Matrex Mold and Tool, Inc., a custom mold manufacturer for plastic injection molding. Matrex produces metal injection production and prototype molds for the medical device, residential, and...
